VEA
KRTX

Virtus ETF Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Virtus ETF Advisers’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-423
Closed -$134K – 492
2023
Q4 		$134K Buy
423
+9
+2% +$1.75K 0.09% 318
2023
Q3 		$70K Sell
414
-39
-9% -$7.33K 0.04% 385
2023
Q2 		$98.2K Sell
453
-44
-9% -$9.43K 0.06% 393
2023
Q1 		$90.3K Sell
497
-188
-27% -$36K 0.05% 365
2022
Q4 		$135K Sell
685
-365
-35% -$78.3K 0.07% 381
2022
Q3 		$236K Buy
1,050
+2
+0.2% +$405 0.09% 300
2022
Q2 		$133K Sell
1,048
-319
-23% -$36.7K 0.05% 343
2022
Q1 		$173K Sell
1,367
-84
-6% -$9.46K 0.08% 210
2021
Q4 		$190K Sell
1,451
-193
-12% -$24.9K 0.07% 229
2021
Q3 		$201K Sell
1,644
-84
-5% -$9.7K 0.09% 270
2021
Q2 		$197K Sell
1,728
-1,458
-46% -$170K 0.08% 356
2021
Q1 		$383K Buy
3,186
+64
+2% +$7.25K 0.16% 190
2020
Q4 		$317K Sell
3,122
-200
-6% -$18.5K 0.13% 195
2020
Q3 		$257K Sell
3,322
-444
-12% -$37.8K 0.13% 256
2020
Q2 		$420K Sell
3,766
-1,750
-32% -$152K 0.2% 182
2020
Q1 		$397K Sell
5,516
-790
-13% -$67.6K 0.16% 199
2019
Q4 		$475K Buy
+6,306
New +$276K 0.08% 209

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Virtus ETF Advisers's KRTX Position: Q1 2024 in Review

Virtus ETF Advisers sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 423 shares — an estimated $134K sold.

Virtus ETF Advisers first reported a position in KRTX in Q4 2019 and held it in 17 quarters. The position peaked at $475K in Q4 2019. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Virtus ETF Advisers reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 423 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $134K.
  • Virtus ETF Advisers first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
  • Virtus ETF Advisers's Karuna Therapeutics, Inc. Common Stock position peaked at $475K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.